Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    17251531 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Prophylaxis Trial of Posaconazole Versus Standard Azole Therapy for Neutropenic Patients (Study P01899)
Conditions: Leukemia, Myelocytic, Acute;   Myelodysplastic Syndromes;   Neutropenia
Intervention: Drug: Posaconazole oral suspension

Study has passed its completion date and status has not been verified in more than two years.